Results 11 to 20 of about 10,059 (251)

Anidulafungin-Induced Suicidal Erythrocyte Death [PDF]

Cellular Physiology and Biochemistry, 2016
Background/Aims: The novel antifungal drug Anidulafungin is used for the treatment of diverse fungal infections including candidiasis and aspergillosis.
Thomas Peter, Rosi Bissinger, Guilai Liu, Florian Lang   +3 more
doaj   +3 more sources

Anidulafungin and its role in candida infections

Infection and Drug Resistance, 2009
Diane M Cappelletty, Rose JungThe University of Toledo, College of Pharmacy, Toledo, OH, USAAbstract: Candida infections continue to play a significant role not only in critically ill and immunocompromised patients but also in non-compromised patients ...
Diane M Cappelletty, Rose Jung
doaj   +5 more sources

Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States. [PDF]

Mycoses
ABSTRACT Background Rezafungin, a novel echinocandin with once‐weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While clinical trial data support its efficacy and safety, real‐world experience remains limited.
Reinhold I, Mori G, Lanzafame M, Limongelli A, Vena A, Götz J, Bauernfeind S, Hanses F, Tometten L, Mayer M, Rieke A, Soriano-Martin A, Valerio M, Vazquez JA, Yue P, Rahimli L, Azimli N, Sal E, Salmanton-García J, Vasenda N, Sprute R, Stemler J, Wingen-Heimann S, Cornely OA, Seidel D.   +24 more
europepmc   +2 more sources

Safety of anidulafungin in solid organ transplant recipients [PDF]

Liver Transplantation, 2012
The aim of this study was the evaluation of the safety of anidulafungin in adult solid organ transplantation (SOT) recipients. During the study period (14 months), we included all consecutive SOT recipients from 14 centers who received anidulafungin for at least 48 hours for the treatment of invasive fungal infections (IFIs ...
José María Aguado, Evaristo Varó, Piedad Usetti, J.C. Pozo, Asunción Moreno, M. Catalán, Óscar Len, Marino Blanes, Amparó Solé, Patricia Muñóz, Miguel Montejo   +10 more
openalex   +6 more sources

In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans-Bacterial Biofilms. [PDF]

APMIS
ABSTRACT The objective was to investigate the effectiveness of anidulafungin (ANI), voriconazole (VOR), and amphotericin (AMB) combined with meropenem against dual biofilms of Candida albicans and Pseudomonas aeruginosa, as well as with daptomycin against dual biofilms of C. albicans–Staphylococcus epidermidis. MIC values of antifungals were determined
Osmani A, Keceli SA, Er DK, Uzuner H, Ercan F, Koroğlu AK.   +5 more
europepmc   +2 more sources

Dynamics of Anidulafungin use in a Tertiary Care Hospital [PDF]

Journal of Clinical and Diagnostic Research, 2014
Dear Editor, Fungal agents have been reported to be more frequently responsible from health care associated infections in recent years [1]. New antifungal agents for invasive fungal infections are introduced to market and we wanted to evaluate our dynamics in use of one of them, the anidulafungin use in our patients with suspected invasive fungal ...
Zeliha Kocak Tufan, Rahmet Guner, Tumer Guven, Gul Ruhsar Yilmaz, Mehmet A. Tasyaran   +4 more
doaj   +7 more sources

EUCAST technical note on anidulafungin [PDF]

Clinical Microbiology and Infection, 2011
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing has determined breakpoints for anidulafungin for Candida spp. This Technical Note is based on the EUCAST anidulafungin rationale document (available at: http://www.eucast.org). Species-specific breakpoints for C.
Arendrup, M.C., Rodriguez-Tudela, J.L., Lass-Florl, C., Cuenca-Estrella, M., Donnelly, J.P., Hope, W.   +5 more
openaire   +4 more sources

A New Antifungal-Loaded Sol-Gel Can Prevent Candida albicans Prosthetic Joint Infection

Antibiotics, 2021
Fungal PJI is one of the most feared complications after arthroplasty. Although a rare finding, its high associated morbidity and mortality makes it an important object of study. The most frequent species causing fungal PJI is C. albicans. New technology
Hugo Garlito-Díaz, Jaime Esteban, Aranzazu Mediero, Rafael Alfredo Carias-Cálix, Beatriz Toirac, Francisca Mulero, Víctor Faus-Rodrigo, Antonia Jiménez-Morales, Emilio Calvo, John Jairo Aguilera-Correa   +9 more
doaj   +1 more source

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazolesusceptible and -resistant Candida albicans [PDF]

Current Medical Mycology, 2022
Background and Purpose: Invasive candidiasis is a life-threatening condition that kills a large number of immunocompromised patients each year worldwide.
narges aslani, Narges Vaseghi, Majid Piramoon, shaghayegh khojasteh, Kiana Abbasi, sahar mohseni, Javad Javidnia, Behrooz Naghili   +7 more
doaj   +1 more source

Anidulafungin for the treatment of invasive candidiasis [PDF]

Clinical Microbiology and Infection, 2011
Candidaemia/invasive candidiasis (C/IC) is the most frequently occurring invasive fungal infection worldwide, with a particularly strong impact and high incidence in the intensive-care unit, where there is a need for new treatment options and strategies. The echinocandin anidulafungin has broad in vitro activity against a wide range of Candida species,
Cornelia Lass-Flörl, Maria Aigner, Astrid Mayr   +2 more
openaire   +3 more sources